Decline of insulin therapy and delays in insulin initiation in people with uncontrolled diabetes mellitus.

Insulin therapy decline is common, potentially leading to progression of hyperglycaemia and a delay in achievement of glycaemic control. Further investigation is needed to determine the reasons, risk factors and long-term outcomes of this important clinical phenomenon.